Veru Inc | DEFA14A: Others
Apr 1 16:34 ET
Veru Inc | 10-Q: Quarterly report
Apr 1 15:48 ET
Veru Inc | 10-K/A: Annual report (Amendment)
Apr 1 15:32 ET
Veru Inc | DEFA14A: Others
Mar 22 16:53 ET
Veru Inc | 8-K: Current report
Feb 28 12:30 ET
Veru Inc | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Feb 15 16:54 ET
Veru Inc | 8-K: Current report
Feb 15 16:11 ET
Veru Inc | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(3.8%),Joseph Edelman(3.8%), etc.
Feb 14 17:39 ET
Veru Inc | 8-K: Veru Inc Announces First Quarter FY2024 Financial Highlights
Feb 8 07:05 ET
Veru Inc | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Phillip Frost, M.D.(3.5%),Frost Gamma Investments Trust(3.5%)
Feb 6 16:35 ET
Veru Inc | 8-K: Current report
Jan 26 16:13 ET
Veru Inc | DEFA14A: Others
Jan 26 09:04 ET
Veru Inc | DEF 14A: Definitive information statements
Jan 26 09:04 ET
Veru Inc | SC 13G: Statement of acquisition of beneficial ownership by individuals-Adage Capital Partners, L.P.(9.50%),Adage Capital Partners GP, L.L.C.(9.50%), etc.
Dec 26, 2023 00:00 ET
Veru Inc | 8-K: Veru Inc Entered into an Underwriting Agreement and Announced Pricing of Public Offering of Common Stock
Dec 18, 2023 09:01 ET
Veru Inc | 424B5: Prospectus
Dec 15, 2023 16:04 ET
Veru Inc | 424B5: Prospectus
Dec 13, 2023 16:23 ET
Veru Inc | 424B5: Prospectus
Dec 13, 2023 16:06 ET
Veru Inc | 8-K: Amendment of a Common Stock Purchase Agreement and Update of the Presentation of 「Discussion Planned Development of Enobosarm Initially as a Treatment」
Dec 13, 2023 16:04 ET
Veru Inc | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Dec 8, 2023 16:02 ET
No Data
No Data